companydata.dkFORWARD PHARMA A/S: Financial statements 2015
CVR: 28865880
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -51,065,000 compared with DKK -13,662,000 the year before. Equity amounted to DKK 176,695,000. The solvency ratio was 98.2%.
- Profit/Loss
- -51,065,000 kr.
- Equity
- 176,695,000 kr.
- Total Assets
- 179,933,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | -51.1 mio. | 176.7 mio. | - |
| 2014 | - | - | -13.7 mio. | 238 mio. | - |
| 2012 | - | -11 mio. | 22.4 mio. | 50.4 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
As of July 20, 2015, Jakob Mosegaard Larsen has joined the board of directors of FORWARD PHARMA A/S.
As of July 20, 2015, Grant Hellier Lawrence has joined the board of directors of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2014. The net result was DKK -13,662,000.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.